Oncology Words matter: The power of language in cancer discussions The priority for any individual diagnosed with cancer is to be provided an effective therapy as quickly as possible.
Views & Analysis Words, inclusivity, and the struggle for health equality Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.
Views & Analysis It’s time for new language in healthcare marketing Healthcare brands need some new terminology and new models.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
